NABRIVA THERAPEUTICS PLC (NBRV) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:NBRV • IE000OZRGNV6

1.42 USD
0 (0%)
At close: Jul 31, 2023
1.3986 USD
-0.02 (-1.51%)
After Hours: 7/31/2023, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

40

ChartMill assigns a Buy % Consensus number of 40% to NBRV. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 1.02. This target is -28.17% below the current price.
  • NBRV was analyzed by 6 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about NBRV.
  • In the previous month the buy percentage consensus was at a similar level.
  • NBRV was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
NBRV Historical Analyst RatingsNBRV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 1.421.011.021.021.05 - -28.87% -28.17% -28.17% -26.06%

Related screens

Find peers 30% below price target
NBRV Current Analyst RatingNBRV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5
Up and Down Grades
Date Firm Action Rating
2022-09-16 Northland Capital Markets Maintains Outperform

NABRIVA THERAPEUTICS PLC / NBRV FAQ

What is the price target for NBRV stock?

6 analysts have analysed NBRV and the average price target is 1.02 USD. This implies a price decrease of -28.17% is expected in the next year compared to the current price of 1.42.


How do analysts rate NABRIVA THERAPEUTICS PLC (NBRV)?

The consensus rating for NABRIVA THERAPEUTICS PLC (NBRV) is 40 / 100 . This indicates that analysts generally have a neutral outlook on the stock.